Insiders · EDIT

EDIT insider transactions

Editas Medicine Inc. (EDIT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for EDIT

• 2d
  SVP, Chief Financial Officer Parison Amy sold $1,253 worth of shares (464 units at $2.70), decreasing direct ownership by 3% to 14,970 units (SEC Form 4) to satisfy tax liability

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 2d
  CEO O'Neill Gilmore Neil sold $41,543 worth of shares (15,380 units at $2.70), decreasing direct ownership by 6% to 248,313 units (SEC Form 4) (for withholding tax)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 2d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $1,975 worth of shares (731 units at $2.70), decreasing direct ownership by 1% to 67,297 units (SEC Form 4) to satisfy withholding tax

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 83d
  SEC Form 4 filed by CEO O'Neill Gilmore Neil

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 83d
  SEC Form 4 filed by SVP, Chief Financial Officer Parison Amy

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 83d
  SEC Form 4 filed by EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 95d
  CEO O'Neill Gilmore Neil sold $10,894 worth of shares (5,394 units at $2.02), decreasing direct ownership by 2% to 263,693 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 95d
  SVP, Chief Financial Officer Parison Amy sold $957 worth of shares (474 units at $2.02), decreasing direct ownership by 3% to 15,434 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 95d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $1,513 worth of shares (749 units at $2.02), decreasing direct ownership by 1% to 68,028 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 185d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $1,535 worth of shares (713 units at $2.15), decreasing direct ownership by 1% to 68,777 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 185d
  CEO O'Neill Gilmore Neil sold $12,064 worth of shares (5,603 units at $2.15), decreasing direct ownership by 2% to 269,087 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 185d
  SVP, Chief Financial Officer Parison Amy sold $993 worth of shares (461 units at $2.15), decreasing direct ownership by 3% to 15,908 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 276d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $1,843 worth of shares (710 units at $2.60), decreasing direct ownership by 1% to 69,490 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 276d
  SVP, Chief Financial Officer Parison Amy sold $1,189 worth of shares (458 units at $2.60), decreasing direct ownership by 3% to 16,369 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 276d
  CEO O'Neill Gilmore Neil sold $14,517 worth of shares (5,592 units at $2.60), decreasing direct ownership by 2% to 274,690 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 303d
  SVP, Chief Financial Officer Parison Amy sold $1,752 worth of shares (679 units at $2.58), decreasing direct ownership by 4% to 16,827 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 307d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $12,757 worth of shares (5,121 units at $2.49), decreasing direct ownership by 7% to 64,398 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 362d
  SEC Form 4 filed by Director Hopfield Jessica

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 362d
  SEC Form 4 filed by Director Scadden David

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 362d
  SEC Form 4 filed by Director Levy Elliott M.

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 362d
  SEC Form 4 filed by Director Connaughton Bernadette

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 362d
  SEC Form 4 filed by Director Hirsch Andrew

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 368d
  SVP, Chief Financial Officer Parison Amy sold $769 worth of shares (446 units at $1.72), decreasing direct ownership by 2% to 17,506 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 368d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $1,252 worth of shares (726 units at $1.72), decreasing direct ownership by 1% to 69,519 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 368d
  CEO O'Neill Gilmore Neil sold $26,196 worth of shares (15,192 units at $1.72), decreasing direct ownership by 5% to 280,282 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 425d
  SEC Form 4 filed by SVP, Chief Financial Officer Parison Amy

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 425d
  New insider Parison Amy claimed ownership of 17,952 shares (SEC Form 3)

  3 - Editas Medicine, Inc. (0001650664) (Issuer)
• 437d
  SEC Form 4 filed by EVP, CHIEF FINANCIAL OFFICER Lucera Erick

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 437d
  SEC Form 4 filed by CEO O'Neill Gilmore Neil

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 437d
  SEC Form 4 filed by EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 459d
  EVP, CHIEF FINANCIAL OFFICER Lucera Erick sold $7,030 worth of shares (4,109 units at $1.71), decreasing direct ownership by 4% to 112,720 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 459d
  CEO O'Neill Gilmore Neil sold $28,452 worth of shares (16,632 units at $1.71), decreasing direct ownership by 5% to 295,474 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 459d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $4,946 worth of shares (2,891 units at $1.71), decreasing direct ownership by 4% to 70,245 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 549d
  CEO O'Neill Gilmore Neil sold $3,361 worth of shares (1,618 units at $2.08), decreasing direct ownership by 0.52% to 312,106 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 549d
  EVP, CHIEF MEDICAL OFFICER Mei Baisong sold $1,124 worth of shares (541 units at $2.08), decreasing direct ownership by 0.40% to 133,354 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 639d
  EVP, CHIEF MEDICAL OFFICER Mei Baisong sold $1,774 worth of shares (518 units at $3.42), decreasing direct ownership by 0.39% to 133,895 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 639d
  CEO O'Neill Gilmore Neil sold $5,325 worth of shares (1,555 units at $3.42), decreasing direct ownership by 0.49% to 313,724 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 681d
  EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda sold $64,370 worth of shares (11,886 units at $5.42), decreasing direct ownership by 14% to 73,136 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 685d
  EVP, CHIEF MEDICAL OFFICER Mei Baisong sold $34,456 worth of shares (6,619 units at $5.21), decreasing direct ownership by 5% to 134,413 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 731d
  O'Neill Gilmore Neil sold $66,997 worth of shares (12,191 units at $5.50), decreasing direct ownership by 4% to 315,279 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 731d
  Mei Baisong sold $2,808 worth of shares (511 units at $5.50), decreasing direct ownership by 0.36% to 141,032 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Scadden David

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Hopfield Jessica

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Chatterjee Meeta

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Hirsch Andrew

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Reeve Emma

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Levy Elliott M.

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Connaughton Bernadette

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 734d
  SEC Form 4 filed by Vaishnaw Akshay

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 746d
  Lucera Erick sold $125,404 worth of shares (22,337 units at $5.61), decreasing direct ownership by 16% to 116,829 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 754d
  Hopfield Jessica bought $253,868 worth of shares (45,000 units at $5.64), increasing direct ownership by 198% to 67,700 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 824d
  Lucera Erick was granted 61,266 shares, increasing direct ownership by 79% to 139,166 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 824d
  Burkly Linda was granted 39,855 shares, increasing direct ownership by 88% to 85,022 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 824d
  O'Neill Gilmore Neil was granted 275,125 shares and sold $732,884 worth of shares (77,824 units at $9.42), increasing direct ownership by 152% to 327,470 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 824d
  Mei Baisong was granted 89,815 shares and sold $191,425 worth of shares (20,327 units at $9.42), increasing direct ownership by 96% to 141,543 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 913d
  Eaton Bruce sold $1,122 worth of shares (103 units at $10.90), decreasing direct ownership by 0.14% to 74,791 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 934d
  Eaton Bruce sold $5,706 worth of shares (695 units at $8.21), decreasing direct ownership by 0.92% to 74,894 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 941d
  Eaton Bruce sold $1,168 worth of shares (139 units at $8.40), decreasing direct ownership by 0.18% to 75,589 units (SEC Form 4)

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 1004d
  SEC Form 4: Eaton Bruce sold $908 worth of shares (103 units at $8.82), decreasing direct ownership by 0.14% to 75,728 units

  4 - Editas Medicine, Inc. (0001650664) (Issuer)
• 1027d
  SEC Form 4: Eaton Bruce sold $6,033 worth of shares (702 units at $8.59), decreasing direct ownership by 0.92% to 75,831 units

  4 - Editas Medicine, Inc. (0001650664) (Issuer)